Intranasal insulin treatment for 6 weeks could decrease anxiety-related behaviors, ameliorate cognitive deficits, enhance the impaired brain insulin signaling, alleviate of Aβ pathology and promote neurogenesis. This evidence concerns the gene INS and Anxiety.